Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 230
Filter
2.
Aust Dent J ; 58 Suppl 1: 66-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23721339

ABSTRACT

The dental industry works in partnership with the dental profession to provide materials, instruments, equipment and resources that help support the profession's desire to provide quality oral care for the population.


Subject(s)
Dental Care/trends , Dental Materials , Dentistry/trends , Health Care Sector/trends , Dental Prosthesis , Dentistry/organization & administration , Diffusion of Innovation , Health Care Sector/organization & administration , Humans , Organ Sparing Treatments/trends , Patient-Centered Care/organization & administration , Patient-Centered Care/trends
4.
Rev Sci Instrum ; 83(10): 10D307, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23126834

ABSTRACT

We report recent progress in the development of RadOptic detectors, radiation to optical converters, that rely upon x-ray absorption induced modulation of the optical refractive index of a semiconductor sensor medium to amplitude modulate an optical probe beam. The sensor temporal response is determined by the dynamics of the electron-hole pair creation and subsequent relaxation in the sensor medium. Response times of a few ps have been demonstrated in a series of experiments conducted at the LLNL Jupiter Laser Facility (JLF). This technology will enable x-ray bang-time and fusion burn-history measurements with ∼ ps resolution.

5.
Aust Vet J ; 90(4): 136-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22443328

ABSTRACT

OBJECTIVE: To determine if canine parvovirus (CPV) or feline panleucopenia virus (FPV) genomic sequences are present in adult feline bone marrow samples. DESIGN: Bone marrow samples were obtained from 32 semi-feral cats that were euthanased at an animal shelter. DNA was extracted and subjected to conventional polymerase chain reaction (PCR) designed to determine if CPV or FPV DNA was present. Positive PCR products were purified, cloned and sequenced to differentiate between CPV and FPV. RESULTS: Eight of the bone marrow samples contained parvoviral DNA (7 CPV, 1 FPV). CONCLUSION: CPV and FPV DNA can be found in the bone marrow of healthy adult cats.


Subject(s)
Bone Marrow/virology , DNA, Viral/analysis , Feline Panleukopenia Virus/isolation & purification , Parvoviridae/isolation & purification , Animals , Animals, Wild , Cat Diseases/epidemiology , Cat Diseases/virology , Cats , Feline Panleukopenia/epidemiology , Feline Panleukopenia/virology , Feline Panleukopenia Virus/genetics , Female , Male , Parvoviridae/genetics , Parvoviridae Infections/epidemiology , Parvoviridae Infections/veterinary , Parvoviridae Infections/virology , Polymerase Chain Reaction/veterinary , Species Specificity
6.
Aust Vet J ; 90(1-2): 34-8, 2012.
Article in English | MEDLINE | ID: mdl-22256983

ABSTRACT

Disseminated Scedosporium prolificans infection in a 1-year-old female spayed German Shepherd dog is described. Clinical signs were predominantly associated with fungal pyelonephritis and the organism was cultured from the urine. The dog was treated with itraconazole and later, terbinafine was added. Subsequent antifungal susceptibility testing of the isolate showed it to be resistant to all available antifungal drugs. The dog was euthanased because of acute abdominal haemorrhage and associated clinical deterioration. Postmortem examination revealed extensive pyogranulomas containing fungal organisms in the renal parenchyma, myocardium, bone marrow, skeletal muscle, liver, lung, spleen, multiple lymph nodes and pancreas.


Subject(s)
Antifungal Agents/therapeutic use , Dog Diseases/diagnosis , Drug Resistance, Multiple, Fungal , Mycoses/veterinary , Scedosporium/isolation & purification , Animals , Dog Diseases/drug therapy , Dog Diseases/microbiology , Dogs , Fatal Outcome , Female , Microbial Sensitivity Tests/veterinary , Mycoses/diagnosis , Mycoses/drug therapy , Mycoses/microbiology
7.
Br J Dermatol ; 165(5): 1011-21, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21787368

ABSTRACT

BACKGROUND: Skin ageing is said to be caused by multiple factors. The relationship with sun exposure is of particular interest because the detrimental cutaneous effects of the sun may be a strong motivator to sun protection. We report a study of skin ageing in participants of an epidemiological study of melanoma. OBJECTIVES: To determine the predictors of periorbital cutaneous ageing and whether it could be used as an objective marker of sun exposure. METHODS: Photographs of the periorbital skin in 1341 participants were graded for wrinkles, degree of vascularity and blotchy pigmentation and the resultant data assessed in relation to reported sun exposure, sunscreen use, body mass index (BMI), smoking and the melanocortin 1 receptor (MC1R) gene status. Data were analysed using proportional odds regression. RESULTS: Wrinkling was associated with age and heavy smoking. Use of higher sun-protection factor sunscreen was protective (P = 0·01). Age, male sex, MC1R variants ('r', P=0·01; 'R', P=0·02), higher reported daily sun exposure (P=0·02), increased BMI (P=0·01) and smoking (P=0·02) were risk factors for hypervascularity. Blotchy pigmentation was associated with age, male sex, higher education and higher weekday sun exposure (P=0·03). More frequent sunscreen use (P=0·02) and MC1R variants ('r', P=0·03; 'R', P=0·001) were protective. CONCLUSIONS: Periorbital wrinkling is a poor biomarker of reported sun exposure. Vascularity is a better biomarker as is blotchy pigmentation, the latter in darker-skinned individuals. In summary, male sex, sun exposure, smoking, obesity and MC1R variants were associated with measures of cutaneous ageing. Sunscreen use showed some evidence of being protective.


Subject(s)
Melanoma/pathology , Skin Aging/radiation effects , Skin Neoplasms/pathology , Sunlight/adverse effects , Adult , Aged , Case-Control Studies , Female , Genotype , Humans , Male , Middle Aged , Obesity/complications , Obesity/pathology , Observer Variation , Orbit , Receptor, Melanocortin, Type 1/genetics , Skin/blood supply , Skin Aging/genetics , Skin Pigmentation , Smoking/adverse effects , Sunburn/pathology
9.
Int J Clin Pract ; 64(6): 775-83, 2010 May.
Article in English | MEDLINE | ID: mdl-20353431

ABSTRACT

BACKGROUND: As obesity prevalence and health-care costs increase, Health Care providers must prevent and manage obesity cost-effectively. METHODS: Using the 2006 NICE obesity health economic model, a primary care weight management programme (Counterweight) was analysed, evaluating costs and outcomes associated with weight gain for three obesity-related conditions (type 2 diabetes, coronary heart disease, colon cancer). Sensitivity analyses examined different scenarios of weight loss and background (untreated) weight gain. RESULTS: Mean weight changes in Counterweight attenders was -3 kg and -2.3 kg at 12 and 24 months, both 4 kg below the expected 1 kg/year background weight gain. Counterweight delivery cost was pound59.83 per patient entered. Even assuming drop-outs/non-attenders at 12 months (55%) lost no weight and gained at the background rate, Counterweight was 'dominant' (cost-saving) under 'base-case scenario', where 12-month achieved weight loss was entirely regained over the next 2 years, returning to the expected background weight gain of 1 kg/year. Quality-adjusted Life-Year cost was pound2017 where background weight gain was limited to 0.5 kg/year, and pound2651 at 0.3 kg/year. Under a 'best-case scenario', where weights of 12-month-attenders were assumed thereafter to rise at the background rate, 4 kg below non-intervention trajectory (very close to the observed weight change), Counterweight remained 'dominant' with background weight gains 1 kg, 0.5 kg or 0.3 kg/year. CONCLUSION: Weight management for obesity in primary care is highly cost-effective even considering only three clinical consequences. Reduced healthcare resources use could offset the total cost of providing the Counterweight Programme, as well as bringing multiple health and Quality of Life benefits.


Subject(s)
Body Weight/physiology , Colonic Neoplasms/complications , Coronary Disease/complications , Diabetes Mellitus, Type 2/complications , Obesity/therapy , Body Mass Index , Colonic Neoplasms/economics , Coronary Disease/economics , Cost-Benefit Analysis , Diabetes Mellitus, Type 2/economics , Female , Follow-Up Studies , Humans , Long-Term Care/economics , Male , Middle Aged , Obesity/economics , Primary Health Care , Quality-Adjusted Life Years
10.
Anaesthesia ; 65(2): 204-6, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20003113

ABSTRACT

A key anaesthetic goal in reconstructive free flap surgery is to maintain optimum blood flow to maximise flap survival. We describe the use of intra-aortic balloon counterpulsation in a patient with severe cardiac dysfunction, in whom surgery was initially felt to be contraindicated.


Subject(s)
Cardiomyopathy, Dilated/complications , Head and Neck Neoplasms/surgery , Intra-Aortic Balloon Pumping/methods , Perioperative Care/methods , Plastic Surgery Procedures/methods , Adult , Humans , Male , Regional Blood Flow , Surgical Flaps/blood supply
11.
Obes Res Clin Pract ; 2(1): I-II, 2008 Mar.
Article in English | MEDLINE | ID: mdl-24351674

ABSTRACT

OBJECTIVES: To examine relationships between body mass index (BMI), prevalence of physician-recorded cardiovascular disease (CVD) risk factors in primary care, and changes in risk with 10% weight change. METHODS: The Counterweight Project conducted a baseline cross-sectional survey of medical records of 6150 obese (BMI ≥ 30 kg/m(2)), 1150 age- and sex-matched overweight (BMI 25 to <30 kg/m(2)), and 1150 age- and sex-matched normal weight (BMI 18.5 to <25 kg/m(2)) controls, in primary care. Data were collected for the previous 18 months to examine BMI and disease prevalence, and then modelled to show the potential effect of 10% weight loss or gain on risk. RESULTS: Obese patients develop more CVD risk factors than normal weight controls. BMI ≥ 40 kg/m(2) exhibits increased prevalence of type 2 diabetes mellitus (DM), odds ratio (OR) men: 6.16 (p < 0.001); women: 7.82 (p < 0.001) and hypertension OR men: 5.51 (p < 0.001); women: 4.16 (p < 0.001). Dyslipidaemia peaked around BMI 35 to <37.5 kg/m(2), OR men: 3.26 (p < 0.001); women 3.76 (p < 0.001) and CVD at BMI 37.5 to <40 kg/m(2) in men, OR 4.48 (p < 0.001) and BMI ≥ 40 kg/m(2) in women, OR 3.98 (p < 0.001). A 10% weight loss from the sample mean of 32.5 kg/m(2) reduced the OR for type 2 DM by 30% and CVD by 20%, while 10% weight gain increased type 2 DM risk by more than 35% and CVD by 20%. CONCLUSION: Obesity plays a fundamental role in CVD risk, which is reduced with weight loss. Weight management intervention strategies should be a public health priority to reduce the burden of disease in the population.

12.
Health Technol Assess ; 10(44): iii-iv, ix-x, 1-210, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17049141

ABSTRACT

OBJECTIVES: To compare patient outcomes, resource use and costs to the NHS and NHS Blood Transfusion Authority (BTA) associated with cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion. DATA SOURCES: Electronic databases covering the period 1996-2004 for systematic reviews and 1994-2004 for economic evidence. REVIEW METHODS: Existing systematic reviews were updated with data from selected randomised controlled trials (RCTs) that involved adults scheduled for elective non-urgent surgery. Any resource use or cost data were extracted for potential use in populating an economic model. Relative risks or weighted mean difference of each outcome for each intervention were assessed, taking into account the number of RCTs included in each outcome and intervention and the presence of any heterogeneity. This allowed indirect comparison of the relative effectiveness of each intervention when the intervention is compared with allogeneic blood transfusion. A decision analytic model synthesised clinical and economic data from several sources, to estimate the relative cost-effectiveness of cell salvage for people undergoing elective surgery with moderate to major expected blood loss. The perspective of the NHS and patients and a time horizon of 1 month were used. The economic model was developed from reviews of effectiveness and cost-effectiveness and clinical experts. Secondary analysis explored the robustness of the results to changes in the timing and costs of cell salvage equipment, surgical procedure, use of transfusion protocols and time horizon of analysis. RESULTS: Overall, 668 studies were identified electronically for the update of the two systematic reviews. This included five RCTs, of which two were cell salvage and three preoperative autologous donation (PAD). Five published systematic reviews were identified for antifibrinolytics, fibrin sealants and restrictive transfusion triggers, PAD plus erythropoietin, erythropoietin alone and acute normovolaemic haemodilution (ANH). Twelve published studies reported full economic evaluations. All but two of the transfusion strategies significantly reduced exposure to allogeneic blood. The relative risk of exposure to allogeneic blood was 0.59 for the pooled trials of cell salvage (95% confidence interval: 0.48 to 0.73). This varied by the type and timing of cell salvage and type of surgical procedure. For cell salvage, the relative risk of allogeneic blood transfusion was higher in cardiac surgery than in orthopaedic surgery. Cell salvage had lower costs and slightly higher quality-adjusted life years compared with all of the alternative transfusion strategies except ANH. The likelihood that cell salvage is cost-effective compared with strategies other than ANH is over 50%. Most of the secondary analyses indicated similar results to the primary analysis. However, the primary and secondary analyses indicated that ANH may be more cost-effective than cell salvage. CONCLUSIONS: The available evidence indicates that cell salvage may be a cost-effective method to reduce exposure to allogeneic blood transfusion. However, ANH may be more cost-effective than cell salvage. The results of this analysis are subject to the low quality and reliability of the data used and the use of indirect comparisons. This may affect the reliability and robustness of the clinical and economic results. There is a need for further research that includes adequately powered high-quality RCTs to compare directly various blood transfusion strategies. These should include measures of health status, health-related quality of life and patient preferences for alternative transfusion strategies. Observational and tracking studies are needed to estimate reliably the incidence of adverse events and infections transmitted during blood transfusion and to identify the lifetime consequences of the serious hazards of transfusion on mortality, health status and health-related quality of life.


Subject(s)
Antifibrinolytic Agents/therapeutic use , Blood Loss, Surgical/prevention & control , Blood Transfusion, Autologous/methods , Hemostatics/therapeutic use , Isotonic Solutions/therapeutic use , Models, Econometric , Perioperative Care/economics , Aminocaproates/economics , Aminocaproates/therapeutic use , Antifibrinolytic Agents/economics , Aprotinin/economics , Aprotinin/therapeutic use , Arthroplasty, Replacement/economics , Blood Transfusion, Autologous/economics , Coronary Artery Bypass/economics , Cost-Benefit Analysis , Crystalloid Solutions , Fibrin Tissue Adhesive/economics , Fibrin Tissue Adhesive/therapeutic use , Hemostatics/economics , Humans , Isotonic Solutions/economics , Perioperative Care/methods , Serine Proteinase Inhibitors/economics , Serine Proteinase Inhibitors/therapeutic use
13.
J Pept Res ; 66(6): 333-47, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16316449

ABSTRACT

A homologous series of nonapeptides and their acetylated versions were successfully prepared using solid-phase synthetic techniques. Each nonapeptide was rich in alpha,alpha-dialkylated amino acids [one 4-aminopiperidine-4-carboxylic acid (Api) and six alpha-aminoisobutyric acid (Aib) residues] and also included lysines or lysine analogs (two residues). The incorporation of the protected dipeptide 9-fluorenylmethyloxycarbonyl (Fmoc)-Aib-Aib-OH improved the purity and overall yields of these de novo designed peptides. The helix preference of each nonapeptide was investigated in six different solvent environments, and each peptide's antimicrobial activity and cytotoxicity were studied. The 3(10)-helical, amphipathic design of these peptides was born out most prominently in the N-terminally acetylated peptides. Most of the peptides exhibited modest activity against Escherichia coli and no activity against Staphylococcus aureus. The nonacetylated peptides (concentrations < or =100 microM) and the acetylated peptides (concentrations < or = 200 microM) did not exhibit any significant cytotoxicity with normal (nonactivated) murine macrophages.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Peptides/chemistry , Peptides/pharmacology , Animals , Anti-Bacterial Agents/chemical synthesis , Cells, Cultured , Circular Dichroism , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/microbiology , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Peptide Fragments , Peptides/chemical synthesis , Proinsulin , Staphylococcus aureus/drug effects
14.
Eur J Clin Nutr ; 59 Suppl 1: S93-100; discussion S101, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16052202

ABSTRACT

OBJECTIVE: To improve the management of obese adults (18-75 y) in primary care. DESIGN: Cohort study. SETTINGS: UK primary care. SUBJECTS: Obese patients (body mass index > or =30 kg/m(2)) or BMI> or =28 kg/m(2) with obesity-related comorbidities in 80 general practices. INTERVENTION: The model consists of four phases: (1) audit and project development, (2) practice training and support, (3) nurse-led patient intervention, and (4) evaluation. The intervention programme used evidence-based pathways, which included strategies to empower clinicians and patients. Weight Management Advisers who are specialist obesity dietitians facilitated programme implementation. MAIN OUTCOME MEASURES: Proportion of practices trained and recruiting patients, and weight change at 12 months. RESULTS: By March 2004, 58 of the 62 (93.5%) intervention practices had been trained, 47 (75.8%) practices were active in implementing the model and 1549 patients had been recruited. At 12 months, 33% of patients achieved a clinically meaningful weight loss of 5% or more. A total of 49% of patients were classed as 'completers' in that they attended the requisite number of appointments in 3, 6 and 12 months. 'Completers' achieved more successful weight loss with 40% achieving a weight loss of 5% or more at 12 months. CONCLUSION: The Counterweight programme provides a promising model to improve the management of obesity in primary care.


Subject(s)
Nutritional Sciences/education , Obesity/therapy , Outcome and Process Assessment, Health Care , Patient Education as Topic , Primary Health Care/methods , Adolescent , Adult , Aged , Clinical Competence , Cohort Studies , Evidence-Based Medicine , Exercise/physiology , Female , Health Promotion/methods , Humans , Life Style , Male , Middle Aged , Obesity/diet therapy , Obesity/drug therapy , Patient Compliance , Physicians, Family , Primary Health Care/standards , Self Efficacy , Treatment Outcome , United Kingdom
15.
Vox Sang ; 88(4): 244-8, 2005 May.
Article in English | MEDLINE | ID: mdl-15877645

ABSTRACT

BACKGROUND AND OBJECTIVES: We investigated the contribution of swab washing to the efficiency of red cell recovery by intraoperative cell salvage (ICS) in 10 patients undergoing elective aortic aneurysm repair. MATERIALS AND METHODS: Volumes and haemoglobin (Hb) concentrations were recorded in the blood recovered by direct suction and from washed swabs, both before and after processing with a Haemonetics Cell Saver 5. RESULTS: The mean +/- standard deviation (SD) estimated blood loss was 991 +/- 403 ml, resulting in a mean +/- SD salvaged RBC volume of 380 +/- 124 ml. The median [interquartile (IQR) range] Hb collected from suction was 84.9 (61.8-131.4) g, of which 50.1 (45-71.5) g was returned to the patient after processing, a median yield of 68 (49-77)%. The swab wash produced a median (IQR) Hb of 39.4 (28.4-64.9) g, of which 26.2 (16.8-31) g was reinfused, a 67 (33-98)% yield. Swab wash thus contributed with a median (IQR) of 31 (24-39)% of the total RBC recovery. CONCLUSIONS: Washing swabs improves the efficiency of red cell recovery by ICS.


Subject(s)
Aortic Aneurysm/surgery , Blood Loss, Surgical/prevention & control , Blood Transfusion, Autologous/methods , Erythrocytes , Elective Surgical Procedures , Hemoglobins/analysis , Humans , Intraoperative Care/methods
16.
Appl Environ Microbiol ; 69(12): 7216-23, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14660369

ABSTRACT

The bacterial communities of aphids were investigated by terminal restriction fragment length polymorphism and denaturing gradient gel electrophoresis analysis of 16S rRNA gene fragments generated by PCR with general eubacterial primers. By both methods, the gamma-proteobacterium Buchnera was detected in laboratory cultures of six parthenogenetic lines of the pea aphid Acyrthosiphon pisum and one line of the black bean aphid Aphis fabae, and one or more of four previously described bacterial taxa were also detected in all aphid lines except one of A. pisum. These latter bacteria, collectively known as secondary symbionts or accessory bacteria, comprised three taxa of gamma-proteobacteria (R-type [PASS], T-type [PABS], and U-type [PAUS]) and a rickettsia (S-type [PAR]). Complementary analysis of aphids from natural populations of four aphid species (A. pisum [n = 74], Amphorophora rubi [n = 109], Aphis sarothamni [n = 42], and Microlophium carnosum [n = 101]) from a single geographical location revealed Buchnera and up to three taxa of accessory bacteria, but no other bacterial taxa, in each aphid. The prevalence of accessory bacterial taxa varied significantly among aphid species but not with the sampling month (between June and August 2000). These results indicate that the accessory bacterial taxa are distributed across multiple aphid species, although with variable prevalence, and that laboratory culture does not generally result in a shift in the bacterial community in aphids. Both the transmission patterns of the accessory bacteria between individual aphids and their impact on aphid fitness are suggested to influence the prevalence of accessory bacterial taxa in natural aphid populations.


Subject(s)
Aphids/microbiology , Bacteria/classification , Genetic Variation , Animals , Bacteria/genetics , Bacteria/isolation & purification , Buchnera/classification , Buchnera/genetics , Buchnera/isolation & purification , DNA, Ribosomal/analysis , Ecosystem , Electrophoresis, Polyacrylamide Gel/methods , Fabaceae/parasitology , Pisum sativum/parasitology , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , RNA, Ribosomal, 16S , Sequence Analysis, DNA
17.
Paediatr Anaesth ; 12(8): 729-32, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12472712

ABSTRACT

A 13-year-old girl presented with right ventricular failure secondary to Ebstein's malformation (downward displacement of the tricuspid valve leaflets with adherence to the right ventricular muscle and redundancy or dysplasia of the tricuspid valve leaflets). She subsequently required a heart transplant but developed rhabdomyolysis early in the postoperative period and required ventilatory support for more than 3 weeks. A variety of causes were considered, but her condition improved only when cyclosporin was eliminated from the immunosuppression regimen. We believe it is likely that the rhabdomyolysis has been caused by cyclosporin. If so, this has occurred both earlier in the clinical course and at lower serum concentrations than previously described.


Subject(s)
Cyclosporine/adverse effects , Heart Transplantation , Immunosuppressive Agents/adverse effects , Rhabdomyolysis/chemically induced , Acute Disease , Adolescent , Anesthetics, Intravenous/therapeutic use , Creatinine/blood , Female , Humans , Piperidines/therapeutic use , Postoperative Complications/chemically induced , Propofol/therapeutic use , Remifentanil
18.
Vox Sang ; 83(3): 254-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12366769

ABSTRACT

BACKGROUND AND OBJECTIVES: To develop a transfusion trigger based on tissue oxygenation, near-infrared spectroscopy (NIRS) was evaluated in a model of compensated haemorrhage. PATIENTS AND METHODS: Regional haemoglobin oxygen saturation from the cerebral cortex (CsO2) and the gastrocnemius muscle (PsO2) was monitored (using an INVOS 4100 near-infrared oximeter) in 30 patients during acute normovolaemic haemodilution to a target haemoglobin of 11 g/dl. Arterial oxygen saturation, end-tidal carbon dioxide tension, mean arterial pressure and haemoglobin concentration were also measured. RESULTS: During blood collection, CsO2 and PsO2 fell by a mean (95% CI) of 8 (5.3-10.7)% (P < 0.001) and 5.5 (3.2-7.8)% (P < 0.001), respectively. Arterial pressure and oxygen saturation did not change, whilst the end-tidal carbon dioxide tension fell by 2.3 (0.8-3.8) mmHg (P = 0.004). Haemoglobin concentration correlated with CsO2 (R = 0.76, P < 0.001) and PsO2 (R = 0.63, P < 0.001), as did the volume of blood removed. CONCLUSIONS: CsO2 and PsO2 fell predictably during compensated blood loss. With further research, NIRS may be developed into a transfusion trigger.


Subject(s)
Blood Transfusion , Oxyhemoglobins/analysis , Spectrophotometry, Infrared/methods , Aged , Cerebral Cortex/blood supply , Decision Making , Female , Hemodilution , Hemorrhage , Humans , Male , Middle Aged , Models, Biological , Muscle, Skeletal/blood supply
19.
Br J Surg ; 89(6): 731-6, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12027982

ABSTRACT

BACKGROUND: This study evaluated the costs of acute normovolaemic haemodilution (ANH) and intraoperative cell salvage (ICS) versus homologous blood transfusion in aortic surgery in a prospective multicentre randomized trial. METHODS: One hundred and forty-five patients were randomized either to standard transfusion practice (homologous) or to a combination of ANH and ICS (autologous). Costs for each inpatient admission were identified. Cell salvage costs were assigned on the assumption that 50 operations were done each year employing a trained cell salvage operator. The results were analysed statistically using bias-corrected bootstrap analysis. RESULTS: Patients who had transfusion of homologous blood received some 251 units and those having a homologous transfusion received 103 units (P = 0.008). There was no difference in morbidity, mortality and duration of hospital stay. Transfusion-related mean costs were similar at 340 UK pounds for patients having a homologous transfusion and 357 UK pounds for those receiving autologous blood (mean difference 17 UK pounds (95 per cent confidence interval [c.i.]--184 UK pounds to 174 UK pounds); P not significant). There was also no significant difference in mean overall costs: 5859 UK pounds for homologous and 5384 UK pounds for autologous transfusion (mean difference--475 UK pounds (95 per cent c.i.--2231 UK pounds to 1342 UK pounds)). Sensitivity analysis showed that costs remained similar for 20 and 150 operations per annum. Exclusion of a dedicated cell salvage operator reduced autologous transfusion costs but did not have a significant impact on overall cost. CONCLUSION: Autologous transfusion is cost neutral in aortic surgery even when surgical activity is low.


Subject(s)
Aortic Aneurysm/surgery , Hemodilution/economics , Intraoperative Care/economics , Adult , Aged , Aged, 80 and over , Blood Transfusion, Autologous , Cost-Benefit Analysis , Hemodilution/methods , Humans , Intraoperative Care/methods , Length of Stay , Middle Aged , Prospective Studies , Salvage Therapy/economics , Salvage Therapy/methods , Sensitivity and Specificity
20.
Intensive Care Med ; 27(8): 1395-400, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11511954

ABSTRACT

OBJECTIVE: To ascertain the activity of major coagulation factors during the first 24 h of extra-corporeal membrane oxygenation (ECMO) used to support hypoxaemic neonates. DESIGN AND SETTING: A prospective observational study in a regional centre for ECMO and paediatric cardiac surgery, placing 15-20 neonates on ECMO per year. PATIENTS: Ten neonates receiving ECMO for severe hypoxaemia. MEASUREMENT AND RESULTS: The activity of major clotting factors, of the inhibitor anti-thrombin III and of markers of blood activation were measured during the first 24 h of neonatal extra-corporeal membrane oxygenation (ECMO) and prior to initiation of ECMO. There was laboratory evidence of factor deficiency and of activation of coagulation at all stages. The initiation of ECMO leads to an initial worsening of coagulopathy, but factor deficiency and abnormal activation of coagulation is also seen prior to ECMO in these very sick neonates. CONCLUSION: If factor deficiency is to be avoided a pro-active approach is required to rapidly correct factor activity. This would include the use of fresh frozen plasma. The effect of such an approach on outcome is at yet uncertain.


Subject(s)
Blood Coagulation Disorders/etiology , Blood Coagulation Factors/metabolism , Extracorporeal Membrane Oxygenation/adverse effects , Hemorrhage/etiology , Hypoxia/therapy , Infant, Premature , Biomarkers/blood , Blood Coagulation Disorders/prevention & control , Blood Transfusion , Hemorrhage/prevention & control , Humans , Hypoxia/complications , In Vitro Techniques , Infant, Newborn , Prospective Studies , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...